Affordability Check
How to afford FENOFIBRIC ACID DELAYED-RELEASE
Generic name: FENOFIBRIC ACID
Pick how you're covered. We'll show you the cheapest legitimate way to get FENOFIBRIC ACID DELAYED-RELEASE — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About FENOFIBRIC ACID DELAYED-RELEASE and its cost
What is this medication? Fenofibric acid delayed-release is a prescription medication belonging to a class of drugs known as fibrates. It is primarily used to treat high levels of triglycerides and cholesterol in the blood. By helping the body increase the natural enzymes that break down fats, the medication works to lower the risk of pancreatitis and other health complications associated with severely elevated lipid levels.
This medication is intended to be used alongside a low-fat diet and lifestyle changes such as regular exercise. It focuses on reducing low-density lipoprotein (LDL) cholesterol and very low-density lipoprotein (VLDL) cholesterol while simultaneously raising high-density lipoprotein (HDL) cholesterol, which is often called good cholesterol. It is important for patients to continue following their prescribed dietary guidelines to maximize the effectiveness of the treatment.
FENOFIBRIC ACID DELAYED-RELEASE is made by AbbVie. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford FENOFIBRIC ACID DELAYED-RELEASE?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for FENOFIBRIC ACID DELAYED-RELEASE?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But AbbVie has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover FENOFIBRIC ACID DELAYED-RELEASE?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Diabetes?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about FENOFIBRIC ACID DELAYED-RELEASE
Full FENOFIBRIC ACID DELAYED-RELEASE drug page
FDA label, prior authorization rules, full indications list
More options for Diabetes
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3